Cargando…

TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters

PURPOSE: Diabetic nephropathy (DN) is a serious microvascular complication in those with type 2 diabetes mellitus (T2DM). Evidence confirms that serum tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the T2DM stage are proposed as prognostic markers for DN development, but it is unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jufang, Feng, Yating, Zhang, Yan, Liu, Jing, Gong, Le, Zhang, Xiaohong, Liao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748123/
https://www.ncbi.nlm.nih.gov/pubmed/36532651
http://dx.doi.org/10.2147/JIR.S391473
_version_ 1784849755739783168
author Wang, Jufang
Feng, Yating
Zhang, Yan
Liu, Jing
Gong, Le
Zhang, Xiaohong
Liao, Hui
author_facet Wang, Jufang
Feng, Yating
Zhang, Yan
Liu, Jing
Gong, Le
Zhang, Xiaohong
Liao, Hui
author_sort Wang, Jufang
collection PubMed
description PURPOSE: Diabetic nephropathy (DN) is a serious microvascular complication in those with type 2 diabetes mellitus (T2DM). Evidence confirms that serum tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the T2DM stage are proposed as prognostic markers for DN development, but it is unclear how they affect renal podocyte-associated nephrin and WT-1 expression. In the presence of podocyte injury, glomerular vascular endothelial growth factor (VEGF), endothelial nitric oxide synthase (eNOS) and hemodynamic parameters are dysregulated. The current research aimed to clarify the relationship of TNF-α and IL-1β with podocyte injury by altering VEGF/eNOS expression and hemodynamic parameters. METHODS: A high-fat diet/streptozotocin-induced DN rat model was established. Serum TNF-α and IL-1β levels were tracked in the pre-T2DM, T2DM and DN stages. In the DN stage, the mRNA and protein expression levels of renal TNF-α, IL-1β, VEGF, eNOS, nephrin and WT-1 were studied. Renal hemodynamic parameters, including peak systolic velocity, end-diastolic flow velocity and mean velocity were measured with a color Doppler ultrasound technique. RESULTS: Compared to those in the normal control (CTL) group, serum TNF-α and IL-1β levels increased significantly in the pre-T2DM stage (obesity, insulin resistance and hyperlipidemia), T2DM stage (hyperglycemia) and DN stage (abnormal renal functions) (all: P < 0.05) in the DN group. Serum TNF-α and IL-1β levels in the T2DM stage were significantly higher than those in the pre-T2DM stage (two: P < 0.05). Compared to the CTL group, renal nephrin, WT-1, TNF-α, IL-1β, eNOS and VEGF expression and hemodynamic parameters in the DN stage all showed significant differences separately (all: P < 0.05). CONCLUSION: Increased serum and renal TNF-α and IL-1β levels played important roles in reducing renal nephrin and WT-1 expression levels, which may be related to the fact that the former affected renal VEGF/eNOS expression and blood flow parameters in the DN rats.
format Online
Article
Text
id pubmed-9748123
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97481232022-12-15 TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters Wang, Jufang Feng, Yating Zhang, Yan Liu, Jing Gong, Le Zhang, Xiaohong Liao, Hui J Inflamm Res Original Research PURPOSE: Diabetic nephropathy (DN) is a serious microvascular complication in those with type 2 diabetes mellitus (T2DM). Evidence confirms that serum tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the T2DM stage are proposed as prognostic markers for DN development, but it is unclear how they affect renal podocyte-associated nephrin and WT-1 expression. In the presence of podocyte injury, glomerular vascular endothelial growth factor (VEGF), endothelial nitric oxide synthase (eNOS) and hemodynamic parameters are dysregulated. The current research aimed to clarify the relationship of TNF-α and IL-1β with podocyte injury by altering VEGF/eNOS expression and hemodynamic parameters. METHODS: A high-fat diet/streptozotocin-induced DN rat model was established. Serum TNF-α and IL-1β levels were tracked in the pre-T2DM, T2DM and DN stages. In the DN stage, the mRNA and protein expression levels of renal TNF-α, IL-1β, VEGF, eNOS, nephrin and WT-1 were studied. Renal hemodynamic parameters, including peak systolic velocity, end-diastolic flow velocity and mean velocity were measured with a color Doppler ultrasound technique. RESULTS: Compared to those in the normal control (CTL) group, serum TNF-α and IL-1β levels increased significantly in the pre-T2DM stage (obesity, insulin resistance and hyperlipidemia), T2DM stage (hyperglycemia) and DN stage (abnormal renal functions) (all: P < 0.05) in the DN group. Serum TNF-α and IL-1β levels in the T2DM stage were significantly higher than those in the pre-T2DM stage (two: P < 0.05). Compared to the CTL group, renal nephrin, WT-1, TNF-α, IL-1β, eNOS and VEGF expression and hemodynamic parameters in the DN stage all showed significant differences separately (all: P < 0.05). CONCLUSION: Increased serum and renal TNF-α and IL-1β levels played important roles in reducing renal nephrin and WT-1 expression levels, which may be related to the fact that the former affected renal VEGF/eNOS expression and blood flow parameters in the DN rats. Dove 2022-12-09 /pmc/articles/PMC9748123/ /pubmed/36532651 http://dx.doi.org/10.2147/JIR.S391473 Text en © 2022 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Jufang
Feng, Yating
Zhang, Yan
Liu, Jing
Gong, Le
Zhang, Xiaohong
Liao, Hui
TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters
title TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters
title_full TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters
title_fullStr TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters
title_full_unstemmed TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters
title_short TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters
title_sort tnf-α and il-1β promote renal podocyte injury in t2dm rats by decreasing glomerular vegf/enos expression levels and altering hemodynamic parameters
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748123/
https://www.ncbi.nlm.nih.gov/pubmed/36532651
http://dx.doi.org/10.2147/JIR.S391473
work_keys_str_mv AT wangjufang tnfaandil1bpromoterenalpodocyteinjuryint2dmratsbydecreasingglomerularvegfenosexpressionlevelsandalteringhemodynamicparameters
AT fengyating tnfaandil1bpromoterenalpodocyteinjuryint2dmratsbydecreasingglomerularvegfenosexpressionlevelsandalteringhemodynamicparameters
AT zhangyan tnfaandil1bpromoterenalpodocyteinjuryint2dmratsbydecreasingglomerularvegfenosexpressionlevelsandalteringhemodynamicparameters
AT liujing tnfaandil1bpromoterenalpodocyteinjuryint2dmratsbydecreasingglomerularvegfenosexpressionlevelsandalteringhemodynamicparameters
AT gongle tnfaandil1bpromoterenalpodocyteinjuryint2dmratsbydecreasingglomerularvegfenosexpressionlevelsandalteringhemodynamicparameters
AT zhangxiaohong tnfaandil1bpromoterenalpodocyteinjuryint2dmratsbydecreasingglomerularvegfenosexpressionlevelsandalteringhemodynamicparameters
AT liaohui tnfaandil1bpromoterenalpodocyteinjuryint2dmratsbydecreasingglomerularvegfenosexpressionlevelsandalteringhemodynamicparameters